The high expression rate of Trop2 in NSCLC tissues with EGFR mutation was 82.10% (64/78), which was higher than that in tissues without EGFR mutation (23.30%, 20/86) (Table 1) (Fig. 1B). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.